
Cardiovascular Drugs / Cardiology Drugs
Prescription drugs and medicines for diseases relating to the structure and function of the heart and blood vessels. Studies in these areas include: heart failure, coronary artery disease, high cholesterol, blood clots, circulation disorders, and others.
The list of FDA approved drugs for cardiology and vascular diseases appears below. Click any link to view the full drug information.
Number Of Cardiovascular Drugs / Cardiology Drugs: 100
For the treatment of pulmonary arterial hypertension
For the treatment of cholesterol disorders
Treatment for Thrombocythemia
Oral tablets for the adjuctive treatment of hypercholesterolemia
For the treatment of uncontrolled hypertension
Treatment for primary and secondary hypogonadism
For patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA)
Anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia.
For the treatment of hypertension
Treatment for hypertension
Treatment for hypertension
For the prevention of peri-operative and peri-partum thromboembolic events
For the treatment of hypertension
Treatment for high cholesterol
Oral tablet for the treatment of hypertension
For the treatment of heart failure in black patients
For the reduction of thrombotic events in patients with acute coronary syndrome
For the treatment of hypertension, chronic stable angina and vasospastic angina
Treatment for hypertension
Generic equivalent of Capozide
Delivery system for Monovial
Treatment for the prevention of organ rejection inpatients undergoing heart transplants
For the treatment of hypertension when oral therapy is not feasible or not desirable
Treatment for severe high blood pressure
Treatment for irregular contractions of the heart
Treatment for hypertension and angina
For the treatment of primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia
For the reduction of high blood pressure
Oral capsules and tablets for the treatment of hypertension
Treatment for hypertension
Treatment for hypertension
Treatment for hypertension
For the treatment of hypertension
For the treatment of hypertension
Treatment for erectile dysfunction
for the prevention of thrombotic cardiovascular complications in acute coronary syndromes
For the treatment of hyperlipidemia, dyslipidemia and hypertriglyceridemia
Ultrasound contrast agent for improved imaging of the heart
For the treatment of acute symptomatic deep vein thrombosis
Oral tablets for the treatment of high blood pressure.
Injection of eptifibatide
Treatment for coronary atherosclerosis
Treatment for the reduction of triglycerides
For the use as an adjunct to diet to reduce elevated total cholesterol
For the treatment of pulmonary arterial hypertension
For the treatment of erectile dysfunction related to sexual activity in men
Treatment for hypertension
For the prevention of cardiovascular disease and treatment of hyperlipidemia and dyslipidemia
For the treatment of primary hyperlipidemia and mixed dyslipidemia
Treatment for hypertension
Treatment for primary prevention of coronary heart disease
Treatment for Hypertension
For the treatment of hypertension
Treatment for mild-to moderate hypertension
For the treatment of paroxysmal or persistent atrial fibrillation or atrial flutter
Treatment for impotence
For the treatment of patients with acutely decompensated congestive heart failure
Niacin extended-release tablets
For the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.
Treatment for deep venous thrombosis
Generic equivalent of Trental
Generic equivalent of Visken
Treatment for cardiac atherosclerotic events
For the treatment of acute coronary syndrome
Treatment for hypertension and chronic stable angina pectoris
For the risk reduction of stroke and embolism due to atrial fibrillation
Treatment for heart disease
Treatment for cholesterol-lowering
Treatment for hypertension, heart failure, and acute myocardial infarction
Treatment for hypotension
Treatment for ventricular arrhythmias
For the treatment of chronic angina in patients failing first-line therapy
For the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms
Treatment for cardiac ischemic complications
Generic equivalent of Pergonal
Treatment for patients suffering from heart attack
Treatment for paroxysmal atrial fibrillation
For the treatment of paroxysmal nocturnal hemoglobinuria
Treatment for hypertension
For the treatment of hypertension
For the treatment of hypertension
Tablets for the treatment of hypertension
Treatment for hypertension
Treatment for chronic stable angina
Treatment for hypertension
Treatment for chronic stable angina
For the treatment of hypertension, angina pectoris and heart failure
For the treatment of hypertension
For the treatment of primary hypercholesterolemia, mixed lipidemia and hypertriglyceridemia
Treatment for very high triglyceride levels
For the treatment of dyslipidemia, hypertriglyceridemia and hyperlipidemia
For the treatment of pulmonary arterial hypertension
For the treatment of hypertriglyceridemia
Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR
Treatment for impotence
Diagnostic contrast agent
Generic equivalent of Coumadin
For the prophylaxis of deep vein thrombosis during knee or hip replacement surgery
For the reduction in the risk of stroke and systemic embolism resulting from atrial fibrillation
Treatment for high cholesterol
FDA Approved Cardiovascular Drugs / Cardiology Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA cardiovascular drugs / cardiology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The cardiovascular drugs / cardiology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



